Rowlings, P A <br/><br/>
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.  [electronic resource] 

 -  JAMA  Oct 1999 
 - 1335-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0098-7484 
<br/><br/><label>Standard No.: </label>10.1001/jama.282.14.1335  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation<br/>Breast Neoplasms--mortality<br/>Chemotherapy, Adjuvant<br/>Disease Progression<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Metastasis<br/>Proportional Hazards Models<br/>Receptors, Estrogen<br/>Risk<br/>Survival Analysis<br/>Tamoxifen--therapeutic use<br/>Transplantation, Autologous<br/>Treatment Failure